Home
Blog
Resources
Why News Quantified Works
The Ultimate Earnings Guide
STOCK MARKET 101
About Us
Contact
Services
Institutions
Market Impact Report
Sign up
Log in
Home
Blog
Resources
Why News Quantified Works
The Ultimate Earnings Guide
STOCK MARKET 101
About Us
Contact
Services
Institutions
Market Impact Report
Log in
Sign up
×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks
Home
DPLO
News
DPLO –
diplomat pharmacy inc
(US:NYSE)
DELAYED
$
usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DPLO
SPY
QQQ
SPX
News
Earning News
Analyst Actions
SEC Filings
Date
Time
Symbol
Headline
Impact
11/14
04:41 pm
dplo
Diplomat Pharmacy: "It Is a Rebuilding Year for Us." [The Motley Fool]
Low
11/13
02:30 am
dplo
Diplomat Pharmacy Inc (NYSE: DPLO) was upgraded by analysts at Zacks Investment Research from a "strong sell" rating to a "hold" rating.
Medium
11/9
02:51 pm
dplo
Diplomat Pharmacy Inc (NYSE: DPLO) had its price target lowered by analysts at Mizuho to $18.00. They now have a "neutral" rating on the stock.
Low
11/8
10:31 am
dplo
Diplomat Pharmacy Inc (NYSE: DPLO) had its price target lowered by analysts at Wells Fargo & Co from $23.00 to $16.00. They now have a "market perform" rating on the stock.
Medium
11/7
04:40 pm
dplo
Here's Why Diplomat Pharmacy Plummeted Today [The Motley Fool]
Medium
11/7
04:01 pm
dplo
Diplomat Pharmacy 2018 Q3 - Results - Earnings Call Slides [Seeking Alpha]
Medium
11/7
03:47 pm
dplo
Diplomat Pharmacy 2018 Q3 - Results - Earnings Call Slides [Seeking Alpha]
Low
11/7
12:01 pm
dplo
Diplomat Pharmacy down 32% after Q3 revenue miss and 83% drop in earnings [Seeking Alpha]
Medium
11/7
11:40 am
dplo
Diplomat Pharmacy down 32% after Q3 revenue miss and 83% drop in earnings [Seeking Alpha]
Medium
11/7
07:30 am
dplo
Diplomat Pharmacy Inc (NYSE: DPLO) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating.
High
11/6
10:46 pm
dplo
Diplomat Pharmacy, Inc. (DPLO) CEO Brian Griffin on Q3 2018 Results - Earnings Call Transcript [Seeking Alpha]
High
11/6
10:40 pm
dplo
Diplomat Pharmacy Inc (DPLO) Q3 2018 Earnings Conference Call Transcript [The Motley Fool]
High
11/6
10:02 pm
dplo
Diplomat Pharmacy, Inc. (DPLO) CEO Brian Griffin on Q3 2018 Results - Earnings Call Transcript [Seeking Alpha]
High
11/6
09:14 pm
dplo
Diplomat Pharmacy Inc (NYSE: DPLO) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.
High
11/6
04:15 pm
dplo
Diplomat Announces 3rd Quarter Financial Results
High
11/6
02:03 am
dplo
Diplomat Pharmacy Inc (NYSE: DPLO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating.
Low
10/23
11:03 pm
dplo
Diplomat Pharmacy Inc (NYSE: DPLO) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating.
Medium
10/23
09:34 pm
dplo
Diplomat Pharmacy Inc (NYSE: DPLO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.
Medium
10/16
04:15 pm
dplo
Diplomat to Release Third-Quarter 2018 Operating Results, Host Conference Call on Nov. 6
Low
10/9
08:30 am
dplo
Market Trends Toward New Normal in Diplomat Pharmacy, Senior Housing Properties Trust, FARO Technologies, Endurance International Group, PolyOne, and NorthWestern — Emerging Consolidated Expectations, Analyst Ratings
Neutral
9/27
08:05 am
dplo
Diplomat Opens Facility in Arizona
Low
9/12
02:03 am
dplo
Diplomat Pharmacy Inc (NYSE: DPLO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating.
Low
8/30
04:05 pm
dplo
Diplomat to Participate in Upcoming Investor Conferences
Low
Live Event:
Click Here To Register For The Live Online Workshop
Latest Posts
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff - Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring NQ Founder and Much More
The Smart Way to Ten Minutes Per Day
How to Win Capital and Influence Markets: Analysts Point To Profits (Even When They're Wrong)